$0 is the total value of Quogue Capital LLC's 0 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | 00 | $0 | – | 0 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-02-18
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Lion Biotechnologies, Inc. | June 13, 2016 | 5,778,947 | 9.6% |
| INFINITY PHARMACEUTICALS, INC.Sold out | June 27, 2013 | 0 | 0.0% |
| PALATIN TECHNOLOGIES INCSold out | February 14, 2013 | 0 | 0.0% |
| REPROS THERAPEUTICS INC.Sold out | February 07, 2013 | 0 | 0.0% |
| PALATIN TECHNOLOGIES INC | February 28, 2011 | 3,646,391 | 9.9% |
| Endo Pharmaceuticals Solutions Inc.Sold out | February 14, 2011 | 0 | 0.0% |
| PHARMACYCLICS INC | February 14, 2011 | 1,500,000 | 2.5% |
| Talon Therapeutics, Inc. | February 14, 2011 | 876,206 | 3.9% |
| PENWEST PHARMACEUTICALS COSold out | February 27, 2009 | 0 | 0.0% |
| REPROS THERAPEUTICS INC.Sold out | February 14, 2007 | 0 | 0.0% |
View Quogue Capital LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-19 |
| SC 13D/A | 2023-10-27 |
| SC 13D/A | 2023-01-13 |
| SC 13D/A | 2018-12-07 |
| SC 13D | 2016-06-13 |
| 13F-HR | 2015-02-18 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
| 13F-HR | 2014-05-15 |
| 13F-HR | 2014-02-14 |
View Quogue Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.